Recent MEIP Stock Price | MEIP Stock Predictions | |
$3.37 | +627.00% |
$24.50 |
Recent MEIP Analyst Ratings Breakdown, Making MEIP Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.0 | 2.0 | 2.0 | 2.0 |
For the MEIP stock predictions from the analysts covering MEI Pharma Inc, we have collected all of the individual MEIP stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 2 different analysts covering MEIP (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MEIP stock predictions may vary widely, another useful metric to consider is the median MEIP stock prediction, which represents the price at which half of the analysts
made MEIP stock predictions that were higher and half made MEIP stock predictions that were lower. This makes for a different take on the MEIP stock predictions out there, as compared to average or mean.
And that median across all the individual MEIP stock predictions was: $24.5 as of 2024-04-23.
The very highest of the MEIP stock predictions for one year price target was $42.0, while the very lowest of the MEIP stock predictions in the analyst group was
$7.0 (with a standard deviation of $24.748). Get the latest Zacks research report on MEIP — FREE
Find out: MEIP next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
UBA Stock Predictions
PATK Stock Predictions
SATS Stock Predictions
AFMD Stock Predictions
OESX Stock Predictions
AVT Stock Predictions
TSCO Stock Predictions
AMED Stock Predictions
WTRH Stock Predictions
|
|
Buy (3.00 out of 4) 33rd percentile
(ranked lower than approx. 67% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |